Cite

HARVARD Citation

    Wu, T. et al. (2021). Apolipoproteins and liver parameters optimize cardiovascular disease risk-stratification in nonalcoholic fatty liver disease. Digestive and liver disease. 53 (12), pp. 1610-1619. [Online]. 
  
Back to record